- Release Date: 12/07/22 09:35
- Summary: Neuren commences Phase 2 trial of NNZ-2591 in Angelman
- Price Sensitive: Yes
- Download Document 154.47KB
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren commences Phase 2 trial of NNZ-2591 in Angelman
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.11%
!
$17.53

Ann: Neuren commences Phase 2 trial of NNZ-2591 in Angelman
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.53 |
Change
-0.020(0.11%) |
Mkt cap ! $2.253B |
Open | High | Low | Value | Volume |
$17.83 | $17.99 | $17.50 | $5.935M | 335.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 630 | $17.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.53 | 81 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 518 | 17.620 |
5 | 222 | 17.610 |
4 | 128 | 17.600 |
6 | 217 | 17.590 |
2 | 293 | 17.580 |
Price($) | Vol. | No. |
---|---|---|
17.630 | 105 | 2 |
17.640 | 76 | 2 |
17.650 | 55 | 2 |
17.660 | 158 | 4 |
17.670 | 214 | 3 |
Last trade - 11.38am 08/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |